research publications

University of Sheffield

2001/2

Ahmed, S.I. and Hancock, B.W. (2001)
Principles of cancer treatment by immunotherapy.
Surgery 19, 58-61.

Ahmed, S.I. and Hancock, B.W. (2001)
The effective management of Non-Hodgkin's Lymphoma.
In: UK Key Advances in Clinical Practice Series 2001.
Eds. Marcus, R., Cunningham, D. & Miles, A. Aesculapius Medical Press.
London, San Francisco, Sydney.
103-118.

Arnaudeau, C., Lundin, C. and Helleday, T. (2001)
DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechansism in mammalian cells.
Journal of Molecular Biology 307, 1235-1245.

Berenson, J.R., Rosen, L.S., Howell, A., Porter, L., Coleman, R.E. et al. (2001)
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.
Cancer 91, 1191-1200.

Blackhall, F.H., Ransom, M., Radford, J.A., Hancock, B.W., Soukop, M., McGown, A.T. et al. (2001)
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.
British Journal of Cancer 84, 465-469.

Bretland, A.J., Lawry, J. and Sharrard, R.M. (2001)
A study of death by anoikis in cultured epithelial cells.
Cell Proliferation 34, 199-210.

Burton, J.L., Lidbury, E.A., Gillespie, A.M., Tidy, J.A., Smith, O., Lawry, J., Hancock, B.W. and Wells, M. (2001)
Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy.
Histopathology 38, 409-417.

Ching, H.Y., Horsman, J.M., Radstone, C.R., Hancock, H., Timperley, W.R. and Hancock, B.W. (2001)
Non-Hodgkin's lymphoma presenting with spinal involvement: the Sheffield Lymphoma Group experience (1970-2000).
International Journal of Oncology 19, 149-156.

Coleman, R.E. (2001)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies.
Cancer Treatment Reviews 27, 165-176.

Coleman, R.E. (2001)
Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseases.
Cancer Treatment Reviews 27, 133-135.

Coleman, R.E. and Seaman, J.J. (2001).
The role of zoledronic acid in Cancer: Clinical Studies in the treatment and prevention of bone metastases.
Seminars in Oncology 28 (suppl 6), 11-16.

Coleman, R.E. (2000)
Endocrine therapy of breast cancer.
In: Breast Cancer: Diagnosis and Management. Ed. Dixon, J.M.
Elsevier, Amsterdam, London, New York, Oxford, Paris, Shannon, Tokyo. 411-420.

Cresswell, A.C., Sisley, K., Laws, D., Parsons, M.A., Rennie, I.G. and Murray, A.K. (2001)
Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease.
Melanoma Research 11, 275-281.

Cunningham, D. and Coleman, R.E. (2001)
New options for outpatient chemotherapy - the role of oral fluoropyrimidines.
Cancer Treatment Reviews 27, 211-220.

Divan, A., Lawry, J., Dunsmore, I.R., Parsons, M.A. and Royds, J.A. (2001)
p53 and p21waf-1expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
Cancer Research 61, 3157-3163.

Gore, M., Huinink, W ten B., Carmichael, J., Gordon A., Davidson, N., Coleman, R. et al. (2001)
Clinical evidence for Topotecan-Paclitaxel non-cross-resistance in ovarian cancer.
Journal of Clinical Oncology 19, 1893-1900.

Hakin-Smith, V., Battersby, R.D., Maltby, E.L., Timperley, W.R. and Royds, J.A. (2001)
Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.
Neuropathology and Applied Neurobiology 27, 40-49.

Hancock, B.W. (2001)
Management of patients with lymphoma: The Way Forward
Clinical Oncology 13, 242.

Hancock, B.W., Gregory, W.M., Cullen, M.H., Vaughan Hudson, G., Burton, A., Selby, P., Maclennan, K.A., Jack, A., et al. (2001) ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease; results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
British Journal of Cancer 84, 1293-1300.

Hough, R.E., Goepel, J.R., Alcock, H.E., Hancock, B.W., Lorigan, P.C. and Hammond, D.W. (2001)
Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma.
British Journal of Cancer 84, 499-503.

Jagdev, S.P., Coleman, R.E., Shipman, C.M., Rostami-H, A. and Croucher, P.I. (2001).
The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
British Journal of Cancer 84, 1126-1134.

Jagdev, S.P., Purohit, O.P., Heatley, S., Herling, C. and Coleman, R.E. (2001)
Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.
Annals of Oncology 12, 1433-1438.

Koh, P.K., Horsman, J.M., Radstone, C.R., Hancock, H., Goepel, J.R. and Hancock, B.W. (2001)
Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998).
International Journal of Oncology 18, 743-748.

Low, S.E., Horsman, J.M., Hancock, H., Walters, S.J. and Hancock, B.W. (2001).
Prognostic markers in malignant lymphoma: An analysis of 1,198 patients treated at a single centre.
International Journal of Oncology 19, 1203-1209.

Major, P.P., and Coleman, R.E. (2001)
Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the International Clinical Development Program.
Seminars in Oncology 28, 17-24.

McJury, M., Fisher, P.M., Pledge, S., Brown, G., Anthony, C., Hatton, M.Q., Conway, J. and Robinson, M.H. (2001)
The impact of virtual simulation in palliative radiotherapy for non-small-cell lung cancer.
Radiotherapy and Oncology 59, 311-318.

McJury, M., Nakielny, R., Levy, D., Lilley, J., Conway, J. and Robinson, M.H. (2001)
Improving the accuracy of localisation in the radiotherapy treatment of head and neck, and brain cancer; some initial findings.
Journal of Radiotherapy in Practice 2, 125-132.

Nutting, C.M., Rowbottom, C.G., Cosgrove, V.P., Henk, J.M., Dearnley, D.P., Robinson, M.H., Conway, J. and Webb, S. (2001).
Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques.
Radiotherapy and Oncology 60, 163-172.

Patel, K.A., Edmondson, N.D., Talbot, F., Parsons, M.A., Rennie, I.G. and Sisley, K. (2001)
Prediction of prognosis in patients wth uveal melanoma using fluorescence in situ hybridisation.
British Journal of Ophthalmology 85, 1440-1444.

Rosen, L.S., Gordon, D., Kaminski, M., Howell, A., Belch, A., Mackey, J., Apffelstaedt, J., Hussein, M., Coleman, R.E. et al. (2001)
Zoledronic acid versus Pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: A Phase III, double-blind, comparative trial.
The Cancer Journal 7, 377-387.

Sulliman, M., Royds, J., Cullen, D., Timperley, W., Powell, T., Battersby, R. and Jones, H. (2001)
Mdm2 and the p53 pathway in human pituitary adenomas.
Clinical Endocrinology 54, 317-325.

Varley, C.L., Royds, J.A., Brown, B.L. and Dobson, P.R.M. (2001)
Interleukin-1 induced synthesis of protein kinase C- and protein kinase C- in EL4 thymoma cells: possible involvement of phosphatidylinositol 3-kinase.
Exp Clin. Immunogenet 18, 135-142.

Vasey, P.A., Atkinson, R., Coleman, R., Crawford, M., Cruickshank, M. et al. on behalf of the Scottish Gynaecological Cancer Trials Group. (2001)
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer.
British Journal of Cancer 84, 170-178.

Zekri, J., Ahmed, N., Coleman, R.E. and Hancock, B.W. (2001)
The skeletal metastatic complications of renal cell carcinoma.
International Journal of Oncology 19, 379-382.